Recent Developments in Salvage Chemotherapy for Patients with Metastatic Soft Tissue Sarcoma

ISSN： 0012-6667

Source： Drugs, Vol.65, Iss.2, 2005-01, pp. : 167-178

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intensified chemotherapy for soft-tissue sarcoma

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

An open label, non-comparative phase II study of topotecan as salvage treatment for patients with soft tissue sarcoma

By Reichardt Peter Oechsle Karin Pink Daniel Bokemeyer Carsten Schneller F. Issels Rolf Kanz Lothar Hartmann Jörg Thomas

Investigational New Drugs, Vol. 21, Iss. 4, 2003-11 ,pp. : 481-486

Springer Publishing Company

Access to resources Recommend Favorite

Systemic Management Strategies for Metastatic Soft Tissue Sarcoma

By Movva Sujana

Drugs, Vol. 71, Iss. 16, 2011-11 ,pp. : 2115-2129

Adis International

Access to resources Recommend Favorite

Role of New Chemotherapy Agents in Soft Tissue Sarcoma

By von Mehren Margaret

Journal of the National Comprehensive Cancer Network (JNCCN), Vol. 3, Iss. 2, 2005-01 ,pp. : 198-205

Cambridge Scholars Publishing in association with GSE Research

Access to resources Recommend Favorite

Trabectedin in pre-treated patients with advanced or metastatic soft tissue sarcoma: a phase II study evaluating co-treatment with dexamethasone

By Paz-Ares Luis

Investigational New Drugs, Vol. 30, Iss. 2, 2012-04 ,pp. : 729-740

Springer Publishing Company

Access to resources Recommend Favorite